Title:
MEDICINAL COMPOSITION
Document Type and Number:
Japanese Patent JP2021183637
Kind Code:
A
Abstract:
To provide therapeutic agents for ophthalmic diseases, comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in nanoparticle form.SOLUTION: The present invention discloses therapeutic agents for ophthalmic diseases, comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.SELECTED DRAWING: None
Inventors:
HANIUDA HIROKI
ENOKIZONO SACHIKO
NAKAZATO TOMOYUKI
TOKUDA TAKUYA
FUJIKI NORIE
ENOKIZONO SACHIKO
NAKAZATO TOMOYUKI
TOKUDA TAKUYA
FUJIKI NORIE
Application Number:
JP2021136152A
Publication Date:
December 02, 2021
Filing Date:
August 24, 2021
Export Citation:
Assignee:
KYOWA KIRIN CO LTD
International Classes:
A61K45/00; A61K9/08; A61K9/14; A61K31/404; A61K31/4365; A61K31/4439; A61K31/47; A61K31/4709; A61K31/496; A61K31/506; A61K47/02; A61K47/06; A61K47/10; A61K47/14; A61K47/16; A61K47/18; A61K47/32; A61K47/38; A61K47/40; A61K47/69; A61P27/02
Domestic Patent References:
| JP2004217649A | 2004-08-05 | |||
| JP2016513108A | 2016-05-12 | |||
| JP2015519331A | 2015-07-09 |
Foreign References:
| WO2004035572A1 | 2004-04-29 |
Other References:
JOURNAL OF CONTROLLED RELEASE, vol. 141, JPN6022034468, 2010, pages 300 - 302, ISSN: 0004851260
Attorney, Agent or Firm:
Yoshiyuki Inaba
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito
Taku Yamada
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito
Taku Yamada